
Commentary|Videos|March 15, 2024
Dr Zaha on the Risk of Cardiovascular Toxicity in Patients With Lung Cancer
Author(s)Vlad Gabriel Zaha, MD, PhD
Vlad Gabriel Zaha, MD, PhD, discusses the risk of cardiovascular toxicity in patients with lung cancer undergoing treatment with radiation.
Advertisement
Vlad Gabriel Zaha, MD, PhD, associate professor, Department of Internal Medicine, UT Southwestern Medical Center, member, Cardiology Division, Harold C. Simmons Comprehensive Cancer Center, discusses the risk of cardiovascular toxicity in patients with lung cancer undergoing treatment with radiation. He emphasizes the importance of recognizing this risk in the treatment landscape.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5



































